Evaluation of serum glucose-regulated protein 78 (GRP78) as a biomarker of treatment response to bortezomib-based induction regimen in multiple myeloma: A cross-sectional pilot study

Suganthi S. Ramachandran(All India Institute of Medical Sciences), Yogendra Kumar Gupta(All India Institute of Medical Sciences Bhopal)
Neoplasma
January 1, 2022
Cited by 2


Related Papers

No related papers found

Powered by citation graph analysis